| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOMATERIALS.2017.10.050 |
| P8608 | Fatcat ID | release_xkm66c4drjf25kbqmrfjyondqy |
| P932 | PMC publication ID | 5768325 |
| P698 | PubMed publication ID | 29117575 |
| P2093 | author name string | Satoshi Saito | |
| Ken Suzuki | |||
| Rakesh Uppal | |||
| Masahiro Kaneko | |||
| Kenichi Yamahara | |||
| Kenji Yamazaki | |||
| Marinos Koulouroudias | |||
| Nobuhiko Sato | |||
| Yuki Ichihara | |||
| P2860 | cites work | The neutral self-assembling peptide hydrogel SPG-178 as a topical hemostatic agent | Q27318565 |
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Multilineage cells from human adipose tissue: implications for cell-based therapies | Q29547688 | ||
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 | ||
| Mesenchymal progenitor cells in human umbilical cord blood | Q30168979 | ||
| Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation | Q30523741 | ||
| Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. | Q33363566 | ||
| Dynamic reassembly of peptide RADA16 nanofiber scaffold | Q33853794 | ||
| Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function. | Q34140406 | ||
| Fabrication of novel biomaterials through molecular self-assembly | Q34266535 | ||
| Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells | Q35097344 | ||
| Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks | Q35227477 | ||
| Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study. | Q35596535 | ||
| Coronary-artery bypass surgery in patients with left ventricular dysfunction | Q36152222 | ||
| Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures | Q36215163 | ||
| Influence of age on rat bone-marrow mesenchymal stem cells potential | Q36297815 | ||
| Molecular mechanisms of RADA16-1 peptide on fast stop bleeding in rat models | Q36432615 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Allogeneic Mesenchymal Stromal Cells Transplanted Onto the Heart Surface Achieve Therapeutic Myocardial Repair Despite Immunologic Responses in Rats | Q36714138 | ||
| The use of scaffold-free cell sheet technique to refine mesenchymal stromal cell-based therapy for heart failure. | Q36740266 | ||
| Stem-cell-based therapy and lessons from the heart | Q37164041 | ||
| Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study | Q37265091 | ||
| Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities | Q37771886 | ||
| Mesenchymal stem cells for cardiac cell therapy. | Q37808214 | ||
| Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. | Q37849930 | ||
| Choice of cell-delivery route for successful cell transplantation therapy for the heart | Q38086843 | ||
| Bone marrow-derived mesenchymal stem cells for the treatment of heart failure | Q38214941 | ||
| Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy | Q38378479 | ||
| Epicardial infarct repair with bioinductive extracellular matrix promotes vasculogenesis and myocardial recovery. | Q38893784 | ||
| Temperature and pH effects on biophysical and morphological properties of self-assembling peptide RADA16-I. | Q40134145 | ||
| A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissection-induced ulcer in the stomach. | Q41096337 | ||
| Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes | Q43052164 | ||
| Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats | Q44288499 | ||
| The use of cell-sheet technique eliminates arrhythmogenicity of skeletal myoblast-based therapy to the heart with enhanced therapeutic effects | Q46498939 | ||
| Isolation and characterization of mesenchymal cells from human fetal membranes | Q46882275 | ||
| Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease. | Q50541878 | ||
| Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. | Q50688973 | ||
| The stiffness of three-dimensional ionic self-assembling peptide gels affects the extent of capillary-like network formation. | Q50900292 | ||
| Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. | Q54489134 | ||
| Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1 | Q61484561 | ||
| Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia | Q81724881 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | hydrogel | Q898925 |
| self-assembly | Q910150 | ||
| P304 | page(s) | 12-23 | |
| P577 | publication date | 2017-10-31 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Self-assembling peptide hydrogel enables instant epicardial coating of the heart with mesenchymal stromal cells for the treatment of heart failure | |
| P478 | volume | 154 |
| Q89529804 | A Cell-Free SDKP-Conjugated Self-Assembling Peptide Hydrogel Sufficient for Improvement of Myocardial Infarction |
| Q94553421 | Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer |
| Q90414200 | Five Decades Later, Are Mesenchymal Stem Cells Still Relevant? |
| Q60948367 | Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction |
| Q91752332 | Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial |
| Q92754010 | Tailorable Hydrogel Improves Retention and Cardioprotection of Intramyocardial Transplanted Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice |
Search more.